Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma.

Literature DB >> 17035308

NKG2C+ NK cells are enriched in AIDS patients with advanced-stage Kaposi's sarcoma.

Martin R Goodier¹, C M Mela, A Steel, B Gazzard, M Bower, F Gotch.

Abstract

Kaposi's sarcoma (KS) is an AIDS-defining condition in individuals with human immunodeficiency virus type 1 infection. We investigated the phenotype and function of the NKG2C+ NK cell population in individuals with AIDS and Kaposi's sarcoma. The staging of AIDS KS patients according to the AIDS Clinical Trial Group criteria revealed that patients with the S1 disease stage have a significantly higher proportion of NKG2C+ cells than those with the S0 disease stage. NKG2C+ cells from S1-stage patients are highly enriched for the expression of KIR3DL1, are depleted of NKp46, and respond poorly to major histocompatibility complex class I-positive target cells. These data demonstrate a link between NK cell phenotype and function and disease prognosis in AIDS.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2006 PMID： 17035308 PMCID： PMC1797234 DOI： 10.1128/JVI.01567-06

Source DB: PubMed Journal: J Virol ISSN： 0022-538X Impact factor: 5.103

23 in total

1. Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma.

Authors: Justin Stebbing; Brian Gazzard; Ornella Flore; Claire Thomas; Adel Benlahrech; Sundhiya Mandalia; Mark Bower; Frances Gotch; Steve Patterson
Journal: AIDS Date: 2003-09-05 Impact factor: 4.177

Review 2. Learning how to discriminate between friends and enemies, a lesson from Natural Killer cells.

Authors: Cristina Bottino; Lorenzo Moretta; Daniela Pende; Massimo Vitale; Alessandro Moretta
Journal: Mol Immunol Date: 2004-07 Impact factor: 4.407

3. Cytomegalovirus seroconversion as a cofactor for progression to AIDS.

Authors: M Robain; F Boufassa; J B Hubert; A Persoz; M Burgard; L Meyer
Journal: AIDS Date: 2001-01-26 Impact factor: 4.177

4. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients.

Authors: Monica Gumá; Cecilia Cabrera; Itziar Erkizia; Margarita Bofill; Bonaventura Clotet; Lidia Ruiz; Miguel López-Botet
Journal: J Infect Dis Date: 2006-05-24 Impact factor: 5.226

5. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors: Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal: Nat Genet Date: 2002-07-22 Impact factor: 38.330

6. The impaired NK cell cytolytic function in viremic HIV-1 infection is associated with a reduced surface expression of natural cytotoxicity receptors (NKp46, NKp30 and NKp44).

Authors: Andrea De Maria; Manuela Fogli; Paola Costa; Giuseppe Murdaca; Francesco Puppo; Domenico Mavilio; Alessandro Moretta; Lorenzo Moretta
Journal: Eur J Immunol Date: 2003-09 Impact factor: 5.532

7. Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors: M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal: Clin Exp Immunol Date: 2003-12 Impact factor: 4.330

8. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy.

Authors: Jane R Deayton; Caroline A Prof Sabin; Margaret A Johnson; Vincent C Emery; Pauline Wilson; Paul D Griffiths
Journal: Lancet Date: 2004-06-26 Impact factor: 79.321

9. NK cell activity controls human herpesvirus 8 latent infection and is restored upon highly active antiretroviral therapy in AIDS patients with regressing Kaposi's sarcoma.

Authors: Maria Caterina Sirianni; Laura Vincenzi; Simone Topino; Antonello Giovannetti; Francesca Mazzetta; Fabio Libi; Donato Scaramuzzi; Massimo Andreoni; Elena Pinter; Sara Baccarini; Giovanni Rezza; Paolo Monini; Barbara Ensoli
Journal: Eur J Immunol Date: 2002-10 Impact factor: 5.532

10. Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates.

Authors: Domenico Mavilio; Janet Benjamin; Marybeth Daucher; Gabriella Lombardo; Shyam Kottilil; Marie A Planta; Emanuela Marcenaro; Cristina Bottino; Lorenzo Moretta; Alessandro Moretta; Anthony S Fauci
Journal: Proc Natl Acad Sci U S A Date: 2003-11-25 Impact factor: 11.205

13 in total

Review 1. Role of natural killer cells in HIV pathogenesis.

Authors: Jeffrey Ward; Edward Barker
Journal: Curr HIV/AIDS Rep Date: 2008-02 Impact factor: 5.071

2. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion.

Authors: Alexander Rölle; Julia Pollmann; Eva-Maria Ewen; Vu Thuy Khanh Le; Anne Halenius; Hartmut Hengel; Adelheid Cerwenka
Journal: J Clin Invest Date: 2014-11-10 Impact factor: 14.808

3. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry.

Authors: Amir Horowitz; Dara M Strauss-Albee; Michael Leipold; Jessica Kubo; Neda Nemat-Gorgani; Ozge C Dogan; Cornelia L Dekker; Sally Mackey; Holden Maecker; Gary E Swan; Mark M Davis; Paul J Norman; Lisbeth A Guethlein; Manisha Desai; Peter Parham; Catherine A Blish
Journal: Sci Transl Med Date: 2013-10-23 Impact factor: 17.956

4. CXCR6⁺ and NKG2C⁺ Natural Killer Cells Are Distinct With Unique Phenotypic and Functional Attributes Following Bone Marrow Transplantation.

Authors: Kevin Aviles-Padilla; Laura S Angelo; Dwight Fan; Silke Paust
Journal: Front Immunol Date: 2022-06-29 Impact factor: 8.786

5. The natural killer cell interferon-gamma response to bacteria is diminished in untreated HIV-1 infection and defects persist despite viral suppression.

Authors: Stephanie M Dillon; Eric J Lee; Julia M Bramante; Edward Barker; Cara C Wilson
Journal: J Acquir Immune Defic Syndr Date: 2014-03-01 Impact factor: 3.731

6. Conserved T cell and natural killer cell function in treatment-experienced adults receiving tenofovir plus didanosine as nucleoside reverse transcription inhibitor backbone.

Authors: P Costa; F Bozzano; D Fenoglio; A Beltrame; G Cenderello; A Di Biagio; G Ferrea; G Pagano; A De Maria
Journal: Clin Exp Immunol Date: 2009-10 Impact factor: 4.330

7. Killing of Kaposi's sarcoma-associated herpesvirus-infected fibroblasts during latent infection by activated natural killer cells.

Authors: Nick C Matthews; Martin R Goodier; Rebecca C Robey; Mark Bower; Frances M Gotch
Journal: Eur J Immunol Date: 2011-05-27 Impact factor: 5.532